Why metformin should not be used as an oxidative phosphorylation inhibitor in cancer patients.
Chemotherapy（2023）
摘要
The value of metformin as an OXPHOS inhibitor for cancer treatment is debatable, and caution should be exercised while using metformin for this purpose.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要